572
Views
20
CrossRef citations to date
0
Altmetric
Cardiology: Original Article

Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin

, , , , , , & show all
Pages 187-194 | Accepted 05 Dec 2011, Published online: 09 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Paul Chan, Li Shao, Brian Tomlinson, Yuzhen Zhang & Zhong-Min Liu. (2019) An evaluation of pitavastatin for the treatment of hypercholesterolemia. Expert Opinion on Pharmacotherapy 20:1, pages 103-113.
Read now
Miao Hu & Brian Tomlinson. (2014) Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin. Expert Opinion on Drug Metabolism & Toxicology 10:1, pages 51-65.
Read now
Vivencio Barrios, Carlos Escobar & José L Zamorano. (2013) Searching the place of pitavastatin in the current treatment of patients with dyslipidemia. Expert Review of Cardiovascular Therapy 11:12, pages 1597-1612.
Read now
Zhenxiang Zhao, Jay Bae, Craig A. Sponseller, Yajun Zhu, Vladimir A. Kryzhanovski & LeRoy A. LeNarz. (2013) Factors associated with statin selection among privately insured commercial and Medicare patients. Current Medical Research and Opinion 29:4, pages 395-404.
Read now

Articles from other publishers (16)

Philip L. Mar, Rakesh Gopinathannair, Brooke E. Gengler, Mina K. Chung, Arturo PerezJonathan DukesMichael D. Ezekowitz, Dhanunjaya Lakkireddy, Gregory Y.H. Lip, Mike Miletello, Peter A. Noseworthy, James Reiffel, James E. Tisdale & Brian Olshansky. (2022) Drug Interactions Affecting Oral Anticoagulant Use. Circulation: Arrhythmia and Electrophysiology 15:6.
Crossref
Mohammadreza Bordbar, Renée de Mutsert, Melike Cevval, Frits R. Rosendaal, J. Wouter Jukema & Willem M. Lijfering. (2021) Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study. Thrombosis Journal 19:1.
Crossref
Anna E. Engell, Andreas L. O. Svendsen, Bent S. Lind, Tore Bjerregaard Stage, Maja Hellfritzsch & Anton Pottegård. (2021) Drug-drug interactions between vitamin K antagonists and statins: a systematic review. European Journal of Clinical Pharmacology 77:10, pages 1435-1441.
Crossref
Larisa O. Minushkina & Dmitry A. Zateyshchikov. (2021) Pitavastatin: focus on safety and drug interactions. CardioSomatics 12:1, pages 48-53.
Crossref
Lucía Cid-Conde & José López-Castro. 2021. Cardiovascular Risk Factors in Pathology. Cardiovascular Risk Factors in Pathology.
Patricia Chaffey, Mary Thompson, Ajit D. Pai, Ali R. Tafreshi, Javad Tafreshi & Ramdas G. Pai. (2018) Usefulness of Statins for Prevention of Venous Thromboembolism. The American Journal of Cardiology 121:11, pages 1436-1440.
Crossref
Nijole Bernaitis, Chi Ching, Siew Teo, Tony Badrick, Andrew Davey, Julia Crilly & Shailendra Anoopkumar-Dukie. (2018) Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore. Journal of Clinical Medicine 7:5, pages 97.
Crossref
Angela Pirillo & Alberico L. Catapano. (2017) Pitavastatin and HDL: Effects on plasma levels and function(s). Atherosclerosis Supplements 27, pages e1-e9.
Crossref
Meng-Syuan Yang, Chung-Ping Yu, Pei-Dawn Lee Chao, Shiuan-Pey Lin & Yu-Chi Hou. (2017) R- and S-Warfarin Were Transported by Breast Cancer Resistance Protein: From In Vitro to Pharmacokinetic-Pharmacodynamic Studies. Journal of Pharmaceutical Sciences 106:5, pages 1419-1425.
Crossref
Nienke van Rein, J. S. Biedermann, S. M. Bonafacio, M. J. H. A. Kruip, F. J. M. van der Meer & W. M. Lijfering. (2016) Statin use decreases coagulation in users of vitamin K antagonists. European Journal of Clinical Pharmacology 72:12, pages 1441-1447.
Crossref
Barbara S. Wiggins, Joseph J. Saseen, Robert L. PageIIII, Brent N. Reed, Kevin Sneed, John B. Kostis, David Lanfear, Salim Virani & Pamela B. Morris. (2016) Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 134:21.
Crossref
Maria Zhelyazkova-Savova, Silvia Gancheva & Vera Sirakova. (2014) Potential statin-drug interactions: prevalence and clinical significance. SpringerPlus 3:1.
Crossref
Zhen Jiang, Ren Rong Gong, Li Qiu, Qian Wang, Mi Su, Xiao Juan Liu, Min Shan Hu, Jia Lin & Ding Zhi Fang. (2014) Efficacy and Safety of Pitavastatin Versus Simvastatin: A Meta-Analysis of Randomized Controlled Trials. Clinical Drug Investigation 34:9, pages 599-608.
Crossref
G.B. John Mancini, A. Yashar Tashakkor, Steven Baker, Jean Bergeron, David Fitchett, Jiri Frohlich, Jacques Genest, Milan Gupta, Robert A. Hegele, Dominic S. Ng, Glen J. Pearson & Janet Pope. (2013) Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Working Group Consensus Update. Canadian Journal of Cardiology 29:12, pages 1553-1568.
Crossref
Shunji Nakagawa, Masahiko Gosho, Yuji Inazu & Neil Hounslow. (2013) Pitavastatin Concentrations Are Not Increased by CYP3A4 Inhibitor Itraconazole in Healthy Subjects. Clinical Pharmacology in Drug Development 2:2, pages 195-200.
Crossref
Luis Masana. (2013) Pitavastatin in cardiometabolic disease: therapeutic profile. Cardiovascular Diabetology 12:Suppl 1, pages S2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.